Rebecca A Snyder1,2, Chung-Yuan Hu3, Syed Nabeel Zafar3, Amanda Francescatti4, George J Chang3,5. 1. Department of Surgery, Brody School of Medicine, East Carolina University, Greenville, NC, USA. 2. Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, NC, USA. 3. Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. 4. American College of Surgeons (ACS) Cancer Programs, Chicago, IL, USA. 5. Department of Health Services Research, MD Anderson Cancer Center, Houston, TX, USA.
Abstract
BACKGROUND: The purpose of this study was to determine the association between race and long-term cancer outcomes (recurrence and overall survival) within a population of US patients with locoregional colorectal cancer (CRC). METHODS: A cohort study of primary patient data merged with the National Cancer Database as part of a Commission on Cancer Special Study was performed. The study population was a random sample of patients undergoing surgery for stage I to III CRC between years 2006 and 2007 with 5 years of follow-up. Propensity-weighted multivariable Cox regression was performed with pooled results to yield statistical inferences. Prespecified sensitivity analysis was performed only for patients who received guideline concordant care (GCC) of primary CRC. All statistical tests were 2-sided. RESULTS: The study population included 8176 patients, 9.9% (n = 811) Black and 90.1% (n = 7365) White. Black patients were more likely to be uninsured or underinsured, have lower household income, and lower educational status (all P < .001). Rates of GCC were higher among Black vs White patients with colon cancer (76.9% vs 72.6%, P = .02), and Black and White patients with rectal cancer were treated with radiation at similar rates (69.1% vs 66.6%, P = .64). Black race was independently associated with increased risk of recurrence (hazard ratio [HR] = 1.48, 95% confidence interval [CI] = 1.26 to 1.73) and mortality (HR = 1.37, 95% CI = 1.18 to 1.59). In sensitivity analysis of only patients who received GCC, observed effects for recurrence (HR = 1.51, 95% CI = 1.27 to 1.79) and overall survival (HR = 1.40, 95% CI = 1.18 to 1.66) persisted. CONCLUSIONS: Despite higher rates of GCC for CRC, Black patients experience a higher risk of recurrence and mortality compared with White patients.
BACKGROUND: The purpose of this study was to determine the association between race and long-term cancer outcomes (recurrence and overall survival) within a population of US patients with locoregional colorectal cancer (CRC). METHODS: A cohort study of primary patient data merged with the National Cancer Database as part of a Commission on Cancer Special Study was performed. The study population was a random sample of patients undergoing surgery for stage I to III CRC between years 2006 and 2007 with 5 years of follow-up. Propensity-weighted multivariable Cox regression was performed with pooled results to yield statistical inferences. Prespecified sensitivity analysis was performed only for patients who received guideline concordant care (GCC) of primary CRC. All statistical tests were 2-sided. RESULTS: The study population included 8176 patients, 9.9% (n = 811) Black and 90.1% (n = 7365) White. Black patients were more likely to be uninsured or underinsured, have lower household income, and lower educational status (all P < .001). Rates of GCC were higher among Black vs White patients with colon cancer (76.9% vs 72.6%, P = .02), and Black and White patients with rectal cancer were treated with radiation at similar rates (69.1% vs 66.6%, P = .64). Black race was independently associated with increased risk of recurrence (hazard ratio [HR] = 1.48, 95% confidence interval [CI] = 1.26 to 1.73) and mortality (HR = 1.37, 95% CI = 1.18 to 1.59). In sensitivity analysis of only patients who received GCC, observed effects for recurrence (HR = 1.51, 95% CI = 1.27 to 1.79) and overall survival (HR = 1.40, 95% CI = 1.18 to 1.66) persisted. CONCLUSIONS: Despite higher rates of GCC for CRC, Black patients experience a higher risk of recurrence and mortality compared with White patients.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Brooke E Sylvester; Dezheng Huo; Andrey Khramtsov; Jing Zhang; Rana V Smalling; Sope Olugbile; Blase N Polite; Olufunmilayo I Olopade Journal: Clin Cancer Res Date: 2011-11-23 Impact factor: 12.531
Authors: Rebecca A Snyder; Chung-Yuan Hu; Amanda Cuddy; Amanda B Francescatti; Jessica R Schumacher; Katherine Van Loon; Y Nancy You; Benjamin D Kozower; Caprice C Greenberg; Deborah Schrag; Alan Venook; Daniel McKellar; David P Winchester; George J Chang Journal: JAMA Date: 2018-05-22 Impact factor: 56.272
Authors: Daniel J Sargent; Harry S Wieand; Daniel G Haller; Richard Gray; Jacqueline K Benedetti; Marc Buyse; Roberto Labianca; Jean Francois Seitz; Christopher J O'Callaghan; Guido Francini; Axel Grothey; Michael O'Connell; Paul J Catalano; Charles D Blanke; David Kerr; Erin Green; Norman Wolmark; Thierry Andre; Richard M Goldberg; Aimery De Gramont Journal: J Clin Oncol Date: 2005-10-31 Impact factor: 44.544
Authors: Federico Innocenti; Fang-Shu Ou; Xueping Qu; Tyler J Zemla; Donna Niedzwiecki; Rachel Tam; Shilpi Mahajan; Richard M Goldberg; Monica M Bertagnolli; Charles D Blanke; Hanna Sanoff; James Atkins; Blasé Polite; Alan P Venook; Heinz-Josef Lenz; Omar Kabbarah Journal: J Clin Oncol Date: 2019-03-13 Impact factor: 44.544
Authors: Hanna K Sanoff; Daniel J Sargent; Erin M Green; Howard L McLeod; Richard M Goldberg Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: Syed Nabeel Zafar; Chung-Yuan Hu; Rebecca A Snyder; Amanda Cuddy; Y Nancy You; Lisa M Lowenstein; Robert J Volk; George J Chang Journal: Ann Surg Oncol Date: 2020-02-20 Impact factor: 5.344
Authors: Heinz-Josef Lenz; Fang-Shu Ou; Alan P Venook; Howard S Hochster; Donna Niedzwiecki; Richard M Goldberg; Robert J Mayer; Monica M Bertagnolli; Charles D Blanke; Tyler Zemla; Xueping Qu; Pratyaksha Wirapati; Sabine Tejpar; Federico Innocenti; Omar Kabbarah Journal: J Clin Oncol Date: 2019-05-01 Impact factor: 50.717
Authors: Joseph M Unger; Charles D Blanke; Michael LeBlanc; William E Barlow; Riha Vaidya; Scott D Ramsey; Dawn L Hershman Journal: JAMA Netw Open Date: 2020-04-01